2019
DOI: 10.1016/j.atherosclerosis.2018.11.016
|View full text |Cite
|
Sign up to set email alerts
|

The important role of apolipoprotein A-II in ezetimibe driven reduction of high cholesterol diet-induced atherosclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
21
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(21 citation statements)
references
References 26 publications
0
21
0
Order By: Relevance
“…In the present study Ezetimibe did not affect ABCA1, ABCG5, ABCG8 and NPC1L1 relative gene expression; similarly a study in hamster measured protein expression of ABCG5, ABCG8, and NPC1L1 showed no change with ezetimibe treatment (During et al, 2005;Naples et al, 2012), While these genes were described to be down-regulated by Ezetimibe in caco 2 cells (During et al, 2005). A recent study showed that Ezetimibe may not only prevent atherosclerosis by inhibiting cholesterol absorption in the intestine, but also by increasing the expression of Apolipoprotein A-II in hepatocytes (Yan et al, 2019). Study in Human showed in accordance with this hypothesis that Ezetimibe increased the efficiency of reverse cholesterol transport from rapidly mixing plasma and tissue cholesterol pools into the stool (Lin et al, 2017).…”
Section: Discussionmentioning
confidence: 95%
“…In the present study Ezetimibe did not affect ABCA1, ABCG5, ABCG8 and NPC1L1 relative gene expression; similarly a study in hamster measured protein expression of ABCG5, ABCG8, and NPC1L1 showed no change with ezetimibe treatment (During et al, 2005;Naples et al, 2012), While these genes were described to be down-regulated by Ezetimibe in caco 2 cells (During et al, 2005). A recent study showed that Ezetimibe may not only prevent atherosclerosis by inhibiting cholesterol absorption in the intestine, but also by increasing the expression of Apolipoprotein A-II in hepatocytes (Yan et al, 2019). Study in Human showed in accordance with this hypothesis that Ezetimibe increased the efficiency of reverse cholesterol transport from rapidly mixing plasma and tissue cholesterol pools into the stool (Lin et al, 2017).…”
Section: Discussionmentioning
confidence: 95%
“…In addition, ezetimibe promotes the expression of apolipoprotein A-II through the HNF4 and PPARα transcription factor in the HCD model (Yan et al, 2019). However, ezetimibe did not inhibit vascular lipid accumulation or macrophage recruitment induced by HCD when apolipoprotein A-II was knocked out, implying that apolipoprotein A-II plays a pivotal role in reducing AS caused by HCD (Yan et al, 2019). The effects of several drugs, including atorvastatin, fenofibrate and ezetimibe, on the cholesterol levels in HCD-fed zebrafish model have been investigated (Chen et al, 2017).…”
Section: Mechanistic Study Of Therapeutic Intervention and Drug Screementioning
confidence: 98%
“…The overexpression of apolipoprotein A-I binding protein (AIBP) mitigates diet-induced metabolic abnormalities, reducing diet-induced lipid accumulation in zebrafish blood vessels, and showing a protective effect from AS (Schneider et al, 2018). In addition, ezetimibe promotes the expression of apolipoprotein A-II through the HNF4 and PPARα transcription factor in the HCD model (Yan et al, 2019). However, ezetimibe did not inhibit vascular lipid accumulation or macrophage recruitment induced by HCD when apolipoprotein A-II was knocked out, implying that apolipoprotein A-II plays a pivotal role in reducing AS caused by HCD (Yan et al, 2019).…”
Section: Mechanistic Study Of Therapeutic Intervention and Drug Screementioning
confidence: 99%
“…zgc:55461 was another gene that was downregulated in both FR70 and FR85 fish, which is predicted to be involved in microtubule cytoskeleton organization and mitotic cell cycle [45]. Commonly upregulated genes from FR70 and FR85 groups include the apoa1b gene, which is predicted to be involved in cholesterol binding, phosphatidylcholine-sterol Oacyltransferase activator, and phospholipid binding activity [46]. Another gene that was upregulated was c6ast1.…”
Section: Rna Sequencing-based Transcriptomic Profilingmentioning
confidence: 99%